Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $67.8273 (0.08%) ($67.3688 - $68.0707) on Wed. Jul. 5, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.74% (three month average) | RSI | 71 | Latest Price | $67.8273(0.08%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 1.1% a week on average for past two weeks. | Market Behavior | Rotation from value to growth for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(61%) VYM(49%) IVE(47%) IWD(47%) SPLV(47%) | Factors Impacting ABBV price | ABBV will decline at least -0.37% in a week (0% probabilities). VIXM(-17%) TLT(-13%) UUP(-11%) IGOV(-4%) IPO(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.37% (StdDev 0.74%) | Hourly BBV | 0 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $67.9(-0.11%) | 10 Day Moving Average | $67.86(-0.05%) | 20 Day Moving Average | $66.81(1.52%) | To recent high | -1% | To recent low | 14.2% | Market Cap | $119.667b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |